ClinicalTrials.gg
CompletedNCT07796529Updated Sep 1, 2026

Menthol Chewing Gum After Laparoscopic Colorectal Surgery

An interventional study of Menthol Chewing Gum in Postoperative Nausea and Vomiting, Bowel Functions and Postoperative Recovery, sponsored by Sennur Kula Şahin. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-01.

Sponsored by Sennur Kula Şahin · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 2 years 7 months after the study started (first participant enrolled Jan 2024, registered Aug 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 96 studies in Postoperative Nausea and Vomiting with a site in Turkey — 22 open to participants now, 23 under way, none of them phase 3. Postoperative Nausea and Vomiting · Turkey.

Enrollment
60th of 71
50 · median 90
Started
2024
with 9 others
No phase
55 of 96
13 open now
Registered
91st of 96
by date

Among the 96 studies in Postoperative Nausea and Vomiting with a site in Turkey, this one is the 60th largest by enrollment of the 71 interventional ones that give a count, is one of 10 that started in 2024, is one of 55 with no phase, and was the 91st registered.

Postoperative Nausea and Vomiting

638 studies on the registry are indexed under Postoperative Nausea and Vomiting; 110 are open to participants now.

Browse Postoperative Nausea and Vomiting studies →

Open to participants now

22 of the 96 studies in Postoperative Nausea and Vomiting with a site in Turkey are open now. Recruiting first, the newest first:

17 more — sign in →

All 22 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 65 Postoperative Nausea and Vomiting studies recruiting now, 22 (34%) set no upper age limit and 37 (57%) stop at 75 or younger; 14 take children under 18; 11 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 96 studies in Postoperative Nausea and Vomiting with a site in Turkey, or all of them as a file.
02

Study summary

This randomized controlled trial was conducted to evaluate the effect of menthol chewing gum on postoperative nausea and vomiting, bowel function, and recovery in patients undergoing laparoscopic colorectal surgery. A total of 50 patients were randomly assigned to an intervention group (n=25) or a control group (n=25). Participants in the intervention group received menthol chewing gum in addition to standard postoperative care, while participants in the control group received standard postoperative care only. Nausea, bowel function, and postoperative recovery were assessed during the first three postoperative days.

Read the detailed description

Postoperative nausea and vomiting and delayed return of bowel function are common concerns following laparoscopic colorectal surgery and may affect postoperative recovery. Chewing gum is a non-pharmacological intervention that may stimulate gastrointestinal activity.

This randomized controlled trial evaluated the effect of menthol chewing gum on postoperative nausea and vomiting, bowel function, and recovery in patients undergoing laparoscopic colorectal surgery. Participants were randomly allocated to an intervention group or a control group.

Both groups received routine postoperative treatment and nursing care. In the intervention group, participants chewed menthol gum for 30 minutes and repeated the intervention three hours later. The same procedure was applied on the first, second, and third postoperative days. Participants in the control group received routine postoperative treatment and care without menthol chewing gum.

Postoperative nausea, bowel function, and recovery status were evaluated during the first three postoperative days. Postoperative recovery was assessed using the Surgical Recovery Status Scale, and nausea intensity was assessed using a Visual Analog Scale.

03

Conditions studied

  • Postoperative Nausea and Vomiting
  • Bowel Functions
  • Postoperative Recovery

Keywords

  • Menthol Chewing Gum
  • Chewing Gum
  • Laparoscopic Colorectal Surgery
  • Postoperative Nausea and Vomiting
  • Bowel Function
  • Surgical Recovery
  • Nonpharmacological Intervention
04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18-60 years
  • Willing to participate in the study
  • At least literate
  • Able to communicate without cognitive, sensory, or verbal impairment
  • No diagnosed psychiatric disorder
  • No vertigo
  • Undergoing elective surgery
  • Not using sedative, anxiolytic, or similar medications
  • Able to speak Turkish
  • Able to chew gum
  • No allergy to menthol or mint
  • No history of jaw or oral surgery

Exclusion criteria

Exclusion Criteria:

  • Absence of teeth
  • Unwilling to chew gum
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    1

    Menthol Chewing Gum Group

    Behavioral: Menthol Chewing Gum

  • No intervention
    2

    Control Group

Interventions

  • BehavioralMenthol Chewing Gum

    Participants chewed menthol gum for 30 minutes, followed by a second 30-minute chewing session three hours later. This intervention was repeated on postoperative days 1, 2, and 3 in addition to standard postoperative care.

06

What researchers measure

Primary outcomes

  1. Postoperative Nausea and Vomiting Frequency

    The frequency of postoperative nausea and vomiting was recorded for each participant during the first three postoperative days. Higher values indicate a greater frequency of nausea and vomiting.

    Time frame: Postoperative days 1, 2, and 3

Secondary outcomes

  1. Postoperative Gas Passage Frequency

    The frequency of defecation was recorded during the first three postoperative days as an indicator of postoperative bowel function.

    Time frame: Postoperative days 1, 2, and 3

Other outcomes

  1. Postoperative Defecation Frequency

    The frequency of defecation was recorded during the first three postoperative days as an indicator of postoperative bowel function.

    Time frame: [Time Frame: Postoperative days 1, 2, and 3]

  2. Postoperative Recovery Status

    Postoperative recovery was assessed using the Surgical Recovery Status Scale. The scale consists of 25 items and five subscales: psychological symptoms, physical activities, general symptoms, bowel symptoms, and desire-related symptoms. Item scores are averaged to obtain the total score. Higher scores indicate greater difficulty in postoperative recovery, whereas lower scores indicate easier recovery.

    Time frame: Postoperative days 1, 2, and 3

07

Study locations

1 site
  • Istinye University Medical Park Gaziosmanpasa Hospital
    Istanbul, Istanbul 34010, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2024 to primary completion in Apr 2024, 3 months.

Of 181 non-industry interventional studies with no phase under Postoperative Nausea and Vomiting, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's 3 months is below that.

Counting every sponsor, half of 181 studies reached it within 13 months; a quarter within 5 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 26, 2026
First posted
Sep 1, 2026
StartActual
Jan 15, 2024
Primary completionActual
Apr 25, 2024
CompletionActual
Apr 25, 2024
Last update
Sep 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07796529
Lead sponsor
Sennur Kula Şahin
Responsible party
Sennur Kula Şahin (Assoc.Prof, Istinye University) — Sponsor-investigator
First posted
Sep 1, 2026
Start date
Jan 15, 2024
Primary completion
Apr 25, 2024
Completion
Apr 25, 2024
Last update
Sep 1, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion